Selected article for: "central nervous system and genetic variation"
Title: 2015 ACVIM Forum Research Abstract Program
  • Document date: 2015_5_27
    • ID: 3pnuj5ru_936
    Snippet: The high prevalence of positive titers in a naive population questions the accuracy of the SHI antibody titer test. Possible false positives caused by cross-reaction with antibodies against phospholipases from soil Corynebacterium spp. or C. pseudotuberculosis biovar ovis warrants further investigation. Equine herpes virus type 1-induced myeloencephalopathy (EHM) is a neurologic disease of horses that occurs as a complication of infection. Neurol.....
    Document: The high prevalence of positive titers in a naive population questions the accuracy of the SHI antibody titer test. Possible false positives caused by cross-reaction with antibodies against phospholipases from soil Corynebacterium spp. or C. pseudotuberculosis biovar ovis warrants further investigation. Equine herpes virus type 1-induced myeloencephalopathy (EHM) is a neurologic disease of horses that occurs as a complication of infection. Neurologic signs result from endothelial cell damage causing vasculitis and ischemic insult to the central nervous system. This disease causes considerable animal suffering and economic loss for the horse industry. Genetic variation in the virus explains some, but not all, of the disease's occurrence.

    Search related documents:
    Co phrase search for related documents
    • antibody titer and false positive: 1, 2, 3
    • antibody titer and high prevalence: 1
    • cell damage and central nervous system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • cell damage and disease occurrence: 1, 2
    • cell damage and high prevalence: 1, 2, 3, 4
    • cell damage and infection complication: 1, 2
    • central nervous system and disease occurrence: 1, 2, 3, 4, 5
    • central nervous system and economic loss: 1, 2
    • central nervous system and false positive: 1
    • central nervous system and genetic variation: 1, 2, 3
    • central nervous system and high prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • central nervous system and infection complication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • disease occurrence and false positive: 1
    • disease occurrence and genetic variation: 1
    • disease occurrence and high prevalence: 1, 2, 3, 4, 5, 6, 7
    • disease occurrence and infection complication: 1, 2
    • disease occurrence explain and genetic variation: 1
    • economic loss and high prevalence: 1, 2, 3, 4
    • economic loss and horse industry: 1